My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

181.21 -1.73 (-0.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

23 24 Next >

Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges ↗

October 13, 2022

The company noted "paradoxical results" where the placebo, at times, topped the drug.

Via Investor's Business Daily

Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket ↗

October 13, 2022

Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech...

Via Benzinga

Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 13, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

3 Red-Hot Stocks That Could Continue to Beat the Market ↗

October 13, 2022

Investors are betting on these companies' revenue growth prospects.

Via The Motley Fool

Better Buy: Moderna vs. Axsome Therapeutics ↗

October 10, 2022

Both of these biotechs offer exciting future prospects.

Via The Motley Fool

Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder ↗

October 03, 2022

Via Benzinga

8 Analysts Have This to Say About Axsome Therapeutics ↗

September 30, 2022

Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:

Via Benzinga

Got $1,000? These 3 Stocks Could Double Your Money in 5 Years. ↗

October 12, 2022

All three stocks are worth keeping a lot longer than half a decade.

Via The Motley Fool

Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold ↗

October 12, 2022

Vertex already generates billions in revenue -- but there may be more to come.

Via The Motley Fool

Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022

October 10, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

These 7 Biotech Stocks Are Set to Boom in 2023 ↗

October 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

Via InvestorPlace

If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today ↗

October 08, 2022

Could the stock keep performing?

Via The Motley Fool

Mizuho Bolsters Price Target By 55% On This Migraine Stock ↗

September 07, 2022

Via Benzinga

Analyst Ratings for Axsome Therapeutics ↗

August 30, 2022

Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings:

Via Benzinga

Expert Ratings for Axsome Therapeutics ↗

August 30, 2022

Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings:

Via Benzinga

Jim Cramer On This Industrial Stock: 'You Don't Know What's In It' ↗

October 07, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Sociedad Quimica y Minera de Chile (NYSE: SQM) as "fertilizer’s in short supply and so is lithium."

Via Benzinga

3 Stocks Savvy Investors Are Buying Hand Over Fist ↗

October 06, 2022

These high-flying stocks are defying the bear market.

Via The Motley Fool

Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea

October 03, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting

September 29, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗

September 20, 2022

We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.

Via Talk Markets

7 Top-Rated Biotech Stocks to Buy for Q4 ↗

September 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

Via InvestorPlace

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry ↗

September 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

Via InvestorPlace

Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗

September 08, 2022

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

September 01, 2022

Via Benzinga

Axsome Therapeutics Commences Late-Stage Migraine Study ↗

September 01, 2022

Axsome Therapeutics (NASDAQ: AXSM) has enrolled the first patient in the EMERGE trial of its lead candidate AXS-07 for the acute treatment of migraine.

Via Benzinga

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock ↗

August 30, 2022

HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday.

Via Benzinga

$1000 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth This Much Today ↗

August 29, 2022

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 57.38% on an annualized basis producing an average annual return of 67.54%. Currently, Axsome Therapeutics has a...

Via Benzinga

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

These names are benefitting from M&A, clinical data and promising regulatory actions.

Via Investor's Business Daily

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.